- Dr. Rinaldo Bellomo of Monash University in Australia, who will moderate the session,
- Dr. Lui Forni of Worthing Hospital in the United Kingdom, who will discuss the role of biomarkers of cell cycle arrest in regards to AKI, and
- Dr. Ivan Gocze of University Hospital Regensburg, Dr. Alex Zarbock of the University of Muenster, and Dr. Christophe Vinsonneau of Paris Descartes University, who will each present case studies describing the utilisation of new AKI biomarkers in everyday routine.
- Astute Medical, Inc., has developed the CE-marked NephroCheck® Test to facilitate the early assessment of moderate or severe AKI risk in the critically ill. The NephroCheck® Test and the Astute140® Meter are on the European market and not available in the United States.
ISICEM 2014: Astute Medical to Host Acute Kidney Injury Symposium
Published on : Tue, 18 Mar 2014
Intended to establish emergency airway access when endotracheal intubation cannot be performed. Features and benefits This comprehensive and compact set provides you with everything you need. Airway access is achieved by using the...
The power of B•R•A•H•M•S with the difference that only VITROS ® can deliver B•R•A•H•M•S PCT is the best biomarker for early bacterial Sepsis Sepsis is a life threatening condition where the body overreacts to an infection. I
Intended for staged extubation and subsequent reintubation. Features and benefits The soft, blunt tip is designed to be atraumatic to internal structures. The distal sideports ensure sufficient airflow and prevent whipping during use...
Taking Lab Productivity to the Next Level Ortho’s full portfolio provides a scalable solution that drives integration across your lab and network. One Connection, Complete Control Ortho’s enhanced middleware solution that allows you...